278 related articles for article (PubMed ID: 3527698)
1. Current problems of chemotherapy of infections with coagulase-negative staphylococci.
Davies AJ; Stone JW
Eur J Clin Microbiol; 1986 Jun; 5(3):277-81. PubMed ID: 3527698
[TBL] [Abstract][Full Text] [Related]
2. Classification and characteristics of coagulase-negative, methicillin-resistant staphylococci.
Wilkinson BJ; Maxwell S; Schaus SM
J Clin Microbiol; 1980 Aug; 12(2):161-6. PubMed ID: 6971871
[TBL] [Abstract][Full Text] [Related]
3. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Klastersky J; Van der Auwera P
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
[TBL] [Abstract][Full Text] [Related]
4. Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.
Schmitz FJ; Mackenzie CR; Hofmann B; Verhoef J; Finken-Eigen M; Heinz HP; Köhrer K
J Med Microbiol; 1997 Sep; 46(9):773-8. PubMed ID: 9291889
[TBL] [Abstract][Full Text] [Related]
5. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Raymond J; Vedel G; Bergeret M
J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance and virulence characterization of Staphylococcus aureus and coagulase-negative staphylococci from imported beef meat.
Osman K; Alvarez-Ordóñez A; Ruiz L; Badr J; ElHofy F; Al-Maary KS; Moussa IMI; Hessain AM; Orabi A; Saad A; Elhadidy M
Ann Clin Microbiol Antimicrob; 2017 May; 16(1):35. PubMed ID: 28486995
[TBL] [Abstract][Full Text] [Related]
7. Linezolid resistance in coagulase-negative staphylococci.
Kelly S; Collins J; Davin M; Gowing C; Murphy PG
J Antimicrob Chemother; 2006 Oct; 58(4):898-9; author reply 899-900. PubMed ID: 16854956
[No Abstract] [Full Text] [Related]
8. Species identification & methicillin resistance of coagulase negative staphylococci from clinical specimens.
Pal N; Ayyagari A
Indian J Med Res; 1989 Sep; 89():300-5. PubMed ID: 2628291
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
Mashaly GE; El-Mahdy RH
Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
[TBL] [Abstract][Full Text] [Related]
10. Activity of LY146032 and vancomycin against coagulase-negative staphylococci.
Low DE; Poon R
Eur J Clin Microbiol; 1987 Apr; 6(2):190. PubMed ID: 3595581
[No Abstract] [Full Text] [Related]
11. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
[TBL] [Abstract][Full Text] [Related]
13. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
Del Bene VE; John JF; Twitty JA; Lewis JW
J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
[No Abstract] [Full Text] [Related]
14. Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.
Rolston KV; Thirolf P; Ho DS; Bodey GP
J Antimicrob Chemother; 1985 Nov; 16(5):659-62. PubMed ID: 3852834
[TBL] [Abstract][Full Text] [Related]
15. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
Hansen-Nord M; Gahrn-Hansen B; Siboni K
APMIS; 1988 Feb; 96(2):133-40. PubMed ID: 3345258
[TBL] [Abstract][Full Text] [Related]
16. Study of coagulase negative staphylococci isolated from blood and CSF cultures.
Seetha KS; Santosh PK; Shivananda PG
Indian J Pathol Microbiol; 2000 Jan; 43(1):41-5. PubMed ID: 12583418
[TBL] [Abstract][Full Text] [Related]
17. Activity of cephalosporins against coagulase-negative staphylococci.
Chin NX; Neu NM; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
[TBL] [Abstract][Full Text] [Related]
18. Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.
Utili R; Tripodi MF; Rosario P; Andreana A; Locatelli A; Rambaldi A; Florio A
New Microbiol; 1996 Oct; 19(4):309-14. PubMed ID: 8914131
[TBL] [Abstract][Full Text] [Related]
19. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase.
John JF; McNeill WF
Antimicrob Agents Chemother; 1980 Feb; 17(2):179-83. PubMed ID: 6966906
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.
Krediet TG; Jones ME; Gerards LJ; Fleer A
Pediatrics; 1999 Mar; 103(3):E29. PubMed ID: 10049985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
